These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 15146825)
21. Access for all? Lange JM; Thaineua V Science; 2004 Jun; 304(5679):1875. PubMed ID: 15218109 [No Abstract] [Full Text] [Related]
22. HIV testing: breaking the deadly cycle. Tarantola D Health Hum Rights; 2005; 8(2):37-41. PubMed ID: 17136901 [No Abstract] [Full Text] [Related]
23. Drugs should be affordable to India's poor to fight HIV/AIDS. Agoramoorthy G; Hsu MJ AIDS; 2006 Oct; 20(15):1988-9. PubMed ID: 16988526 [No Abstract] [Full Text] [Related]
24. There's nothing routine about HIV. CDC's recommendations for HIV testing. Sharp M Posit Aware; 2007; 18(2):14. PubMed ID: 17390483 [No Abstract] [Full Text] [Related]
25. Treating HIV in the developing world: getting ahead of the drug development curve. Ford N; Calmy A; von Schoen-Angerer T Drug Discov Today; 2007 Jan; 12(1-2):1-3. PubMed ID: 17198967 [No Abstract] [Full Text] [Related]
26. Rapid tests could mean trouble for ADAPS. Increased HIV testing could flood system. AIDS Alert; 2003 Oct; 18(10):129-30. PubMed ID: 14686300 [TBL] [Abstract][Full Text] [Related]
27. Clinton brokers deal to lower price of antiretrovirals. Abimbola S BMJ; 2007 May; 334(7602):1026. PubMed ID: 17510129 [No Abstract] [Full Text] [Related]
28. Drug pricing. AHF praises U.S. drugmaker for AIDS drug price freeze. AIDS Policy Law; 2008 Sep; 23(10):9. PubMed ID: 18814367 [No Abstract] [Full Text] [Related]
30. HIV testing in the era of treatment scale up. De Cock KM Health Hum Rights; 2005; 8(2):31-5. PubMed ID: 17136900 [No Abstract] [Full Text] [Related]
31. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations. Pinheiro Edos S; Antunes OA; Fortunak JM Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246 [TBL] [Abstract][Full Text] [Related]
32. Starting therapy earlier found to improve survival. Study raises the implications of more testing, less transmission. Vázquez E Posit Aware; 2009; 20(1):23-4. PubMed ID: 19205096 [No Abstract] [Full Text] [Related]
33. World CAB. Focus on international drug pricing. GMHC Treat Issues; 2004; 18(1-2):8-13. PubMed ID: 15119275 [No Abstract] [Full Text] [Related]
34. Glaxo drops drug prices, AIDS foundation drops suit. AIDS Policy Law; 2003 May; 18(10):6. PubMed ID: 12809097 [No Abstract] [Full Text] [Related]
35. Rapid HIV tests make comeback. AIDS Alert; 2001 Oct; 16(10):130. PubMed ID: 11590932 [No Abstract] [Full Text] [Related]
36. Clinton Foundation negotiates $140/Year HIV treatment, but U.S. won't buy. James JS AIDS Treat News; 2004 Mar; (399):2-4. PubMed ID: 15199865 [TBL] [Abstract][Full Text] [Related]
38. HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Maponga CC; Ma Q; Slish JC; Morse GD Top HIV Med; 2007; 15(3):104-10. PubMed ID: 17598930 [TBL] [Abstract][Full Text] [Related]
39. Paying for life. The issues behind drug pricing. Huff B GMHC Treat Issues; 2003 Nov; 17(11):1-7. PubMed ID: 14717105 [No Abstract] [Full Text] [Related]